Medicare news from FiercePharma
News
Medicare peeved by PBM markups
SPOTLIGHT: Medicare peeved by PBM markupsMedicare wants to curb lock-in drug pricing, under which some pharmacy benefits managers mark up drugs they sell to health insurers -- and ultimately, the Read more...
Medicare drug coverage costs more this year
Most seniors in Medicare's prescription-drug program are paying considerably higher monthly premiums this year, according to a new study; we'll have to wait and see whether the higher costs force Read more...
Avastin-Lucentis trial may reshape pharma
We thought the head-to-head trial of Avastin and Lucentis for age-related macular degeneration was a big deal for Genentech, which Read more...
Congress probes Amgen, J&J promos
Did Amgen and Johnson & Johnson over-promote their anemia drugs? Congress is asking the companies for documents detailing their advertising and promotions, including a "bundling" discount Amgen Read more...
NIH launches Avastin-Lucentis trial
Gentlemen (and ladies), start your eye injections. In other Avastin news, the big trial pitting the cancer drug against Genentech sister med Lucentis is now underway. Sponsored by the National Read more...
AZ to appeal$215M Alabama judgment
A jury hit AstraZeneca with $215 million in damages as paybacks for overcharging the state of Alabama for drugs for 15 years. And AstraZeneca is just the first of 70 drug makers to go to trial. In Read more...
Medicare: Right to restrict anemia meds
A Medicare official says there's an even better case now for restricting payments for Amgen Read more...
Canada to decide Lucentis' fate
The Lucentis versus Avastin match has moved to Canada. Officials there are arguing Read more...
Cut co-pays, sell more drugs?
You'd have to be one of the Three Stooges to disagree with the following statement: If you pay less for drugs, you're more likely to keep taking them. Duh, right? But actually, the issue of Read more...
Medicare boosted 2006 drug spending
Thank you, Medicare. Prescription drug spending surged in 2006 as the government's benefits for the elderly kicked in, according to a federal study. Some $216 billion was spent on prescriptions in Read more...
Get more Medicare coverage at:
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets